| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : 2007 : ASCPT 2007 : Model-Based Evaluations to Select and Confirm Doses in the Clinical Development of Exenatide | published Mon, Nov 10, 2008 - 15:27 EST |
Cognigen's Primary Author: Luann Phillips, Amylin Pharmaceuticals Primary Author: Mark Fineman
Primary Authors: Mark Fineman, Amylin Pharmaceuticals, Inc. San Diego, CA; Luann Phillips, Cognigen Corporation, Buffalo, NY
Event: American Society for Clinical Pharmacology and Therapeutics, March 21-24, 2007, Aneheim, CA
Amylin Pharmaceuticals, Inc. Contributing Authors:
K. Taylor
A. Baron
Eli Lilly and Company Contributing Authors:
P. Kothare
Cognigen Corporation Contributing Authors:
D. Jaworowicz
B. Cirincione
E. Ludwig
T. Grasela
| Cognigen Corporation - Posters and Presentations : 2007 : ASCPT 2007 : Model-Based Evaluations to Select and Confirm Doses in the Clinical Development of Exenatide | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |